Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Ajibade O Ashaye"'
Autor:
Nathan R. Hill D.Phil, Belinda Sandler MBBS, BSc, MRCP, Evelien Bergrath MSc, Dušan Milenković MSc, Ajibade O. Ashaye MD, MBA, MPH, MSc, Usman Farooqui MFPM, MSc, Alexander T. Cohen MD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 26 (2020)
There is no direct evidence comparing the 2 most commonly prescribed direct oral anticoagulants, apixaban and rivaroxaban, used for stroke prevention in nonvalvular atrial fibrillation (NVAF). A number of network meta-analyses (NMAs) of randomized co
Externí odkaz:
https://doaj.org/article/b2d4ab2d652647c2838ca0703c1c6230
Autor:
Heather Burnett, Hemangi Panchmatia, Olga Ovcinnikova, S. Abogunrin, Ajibade O Ashaye, Mehul Dalal
Publikováno v:
Future oncology (London, England). 18(4)
Plain language summary Peripheral T-cell lymphoma (PTCL) is an aggressive cancer that develops from white blood cells called T cells, which are an important part of the immune system. There is limited knowledge on the impact PTCL has on patients and
Publikováno v:
Expert review of hematology. 13(8)
To assess evidence on the safety and efficacy of ABVD (doxorubicin [Adriamycin®], bleomycin, vinblastine, and dacarbazine), BEACOPP (bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone), and A+AVD (brentuxi
Autor:
Hill, Nathan R., Sandler, Belinda, Bergrath, Evelien, Dušan Milenković, Ajibade O. Ashaye, Farooqui, Usman, Cohen, Alexander T.
BOE_Manuscript_CATH_Supplementary_20191004 for A Systematic Review of Network Meta-Analyses and Real-World Evidence Comparing Apixaban and Rivaroxaban in Nonvalvular Atrial Fibrillation by Nathan R. Hill, Belinda Sandler, Evelien Bergrath, Dušan Mil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c649f4f299094e9a4abc7c42ed246700
Autor:
Belinda Sandler, Alexander T. Cohen, Nathan R. Hill, Usman Farooqui, Evelien Bergrath, Dušan Milenković, Ajibade O Ashaye
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis
Clinical and Applied Thrombosis/Hemostasis, Vol 26 (2020)
Clinical and Applied Thrombosis/Hemostasis, Vol 26 (2020)
There is no direct evidence comparing the 2 most commonly prescribed direct oral anticoagulants, apixaban and rivaroxaban, used for stroke prevention in nonvalvular atrial fibrillation (NVAF). A number of network meta-analyses (NMAs) of randomized co
Autor:
Ajibade O Ashaye, Mehul Dalal, K. Marsh, Nicolas Krucien, E. Weiss, Vamsi Kota, M. Sae-Hau, Steven C. Campbell, M. Barnhart, C. Thomas
Publikováno v:
European Journal of Cancer. 138:S51-S52
Autor:
Shelby Corman, Christopher P. Fox, Mehul Dalal, Lorenz Truemper, Ruchit Shah, Ajibade O Ashaye
Publikováno v:
Blood. 134:3482-3482
INTRODUCTION Peripheral T cell lymphomas (PTCL) are a rare and heterogenous group of aggressive non-Hodgkin lymphomas (NHL) that develop from mature T- and natural killer cells. They comprise approximately 10% of all newly diagnosed cases of NHL in W
Autor:
Enchi Liu, Ajibade O. Ashaye, Karin Travers, Lauren Strand, Kelly Olsson, Gian Luca Tanna, Kevin Booth, Scot Styren, H. Robert Brashear, Johannes Rolf Streffer
Publikováno v:
Alzheimer's & Dementia. 10